Loading...
Market
How many research papers will cite OncoGAN's synthetic genomes by October 2025?
2
Resolution / Starting Odds
Less than 50 • 25%
50 to 100 • 25%
101 to 200 • 25%
More than 200 • 25%
Academic databases and citation indexes
Story
New AI Pipeline OncoGAN Generates Synthetic Cancer Genomes, Addressing Privacy Concerns
Oct 21, 2024, 05:57 AM
A novel AI-based pipeline called OncoGAN has been introduced to generate realistic synthetic cancer genomes using generative adversarial networks (GANs) and tabular variational autoencoders (VAEs). This approach addresses the limitations of real patient genomic data due to privacy concerns. The development of OncoGAN aims to facilitate research in precision oncology by providing high-quality synthetic genomic data for algorithm development and benchmarking.
View original story
Similar markets
0-10 papers • 25%
11-20 papers • 25%
21-30 papers • 25%
31+ papers • 25%
Yes • 50%
No • 50%
Less than 50 • 25%
50-100 • 25%
101-200 • 25%
More than 200 • 25%
1-5 articles • 33%
6-10 articles • 33%
11+ articles • 34%
0-10 • 25%
11-20 • 25%
21-30 • 25%
31+ • 25%
Less than 50 • 33%
50-100 • 33%
More than 100 • 34%
0-500 • 25%
501-1000 • 25%
1001-1500 • 25%
1501 or more • 25%
Above 50 • 25%
30 - 50 • 25%
10 - 30 • 25%
Below 10 • 25%
Less than 10 • 25%
10 to 20 • 25%
21 to 30 • 25%
More than 30 • 25%